Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.

Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.

<h4>Background</h4>To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.<h4>Methods</h4>Multicohort study...

Full description

Bibliographic Details
Main Authors: Mar Pujades-Rodríguez, Emmanuelle Dantony, Loretxu Pinoges, René Ecochard, Jean-François Etard, Esther Carrillo-Casas, Elisabeth Szumilin, AIDS Working Group of Médecins Sans Frontières
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22132226/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22132226/?tool=EBI

Similar Items